Precautions while using budesonide delayed-release capsules (Tarpeyo)

Budesonide delayed-release capsules (trade nameTarpeyo), as an innovative treatment for primary immunoglobulin A nephropathy (IgAN), have brought new hope to many patients. However, to ensure the safety and effectiveness of the drug, special attention should be paid to the following matters during use.

First, be sure to tell your doctor in detail about your medical condition. This includes liver problems, upcoming surgery, history and recent exposure to chickenpox or measles, high blood sugar (whether pre-diabetic or established diabetes), glaucoma or cataracts, a family history of diabetes or glaucoma, a history of tuberculosis, high blood pressure, reduced bone density (such as osteoporosis), stomach ulcers, a weakened immune system (due to illness or certain medications), and pregnancy or breastfeeding.

For women who are pregnant or planning to become pregnant, budesonide delayed-release capsules may cause potential harm to the fetus. Therefore, when taking this medicine during pregnancy, be sure to consult your doctor to learn about the risks. Also, for mothers who are breastfeeding or planning to breastfeed, it is not known whether this drug passes into breast milk or has any effects on the baby. In this case, the best feeding options during breastfeeding should be discussed with your doctor, and your baby's growth may need to be monitored regularly.

In terms of contraindications, patients who are allergic to any of the ingredients in budesonide delayed-release capsules should strictly avoid using this drug. Additionally, grapefruit may interact with budesonide, causing side effects, so grapefruit and its related products should be avoided during use.

In daily life, patients using budesonide delayed-release capsules should try to avoid contact with sick or infected people. If you are exposed to infectious diseases such as chickenpox or measles, you should contact your doctor immediately for preventive treatment, because these infectious diseases may have serious and even life-threatening consequences for patients taking this medicine.

Drug interactions are also an important aspect to be aware of when using budesonide delayed-release capsules. Patients should tell their doctors and pharmacists about all prescription drugs, over-the-counter drugs, vitamins, nutritional supplements, and herbal products that they are using or plan to use. Certain medications may interact with budesonide, affecting its effectiveness or increasing the risk of side effects.

Finally, regarding the storage of the drug, budesonide delayed-release capsules should be stored at room temperature, i.e. 20-25°C (68-77°F), with a range of 15-30°C (59-86°F) allowed. At the same time, make sure the container is tightly closed to prevent moisture.

In short, patients should fully understand and follow the above precautions when using budesonide delayed-release capsules. If you have any questions or discomfort, you should contact your doctor or pharmacist immediately for consultation.

Reference materials:https://www.drugs.com/history/tarpeyo.html

xa0

xa0